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META-ANALYSIS REVIEW: 
MRI is the most effective initial diagnostic 
study for osteomyelitis of the foot              
in diabetic patients 
ANTHONY M. PROVENZANO, B.A., Wayne State University, Detroit, MI, aprovenz@med.wayne.edu  
 
ABSTRACT What is the best initial diagnostic study that should be used for a suspected osteomyelitis diagnosis? A critical 
review and clinical application of: Kapoor A, Page S, LaValley M, Gale DR, Felson DT. Magnetic resonance imaging for diagnosing foot 
osteomyelitis: a meta-analysis. Arch Intern Med. 2007;167(2):125-132. doi:10.1001/archinte.167.2.125. Keywords: foot 
osteomyelitis, MRI, magnetic resonance imaging, diabetes, diagnostic methods, Charcot joint 
 
Clinical Context 
During our infectious disease rounds, we had a patient with suspected osteomyelitis due to a painful toe joint with 
overriding necrotic ulceration; the patient also had diabetes as comorbidity. Our attending decided to order an 
MRI (magnetic resonance imaging) as the initial study to work up the possible osteomyelitis. This confused me be-
cause at other clerkship sites, we had done bone scans as the initial diagnostic work-up for osteomyelitis. 
Clinical Question 
What is the best initial diagnostic study that should be used for a suspected osteomyelitis diagnosis? 
Research Article 
Kapoor A, Page S, LaValley M, Gale DR, Felson DT. Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis. 
Arch Intern Med. 2007;167(2):125-132. doi:10.1001/archinte.167.2.125. 
Literature Review 
The above-identified research article, provided by a mentor, examined the four most widely used diagnostic tests for osteomyelitis. 
Keywords derived from this meta-analysis led to multiple prospective trials relevant to the topic of osteomyelitis diagnosis in 
diabetic patients using MRI. All of the studies included1-38 had small sample sizes (the largest was only 72)1, and many were not 
designed prospectively nor were they randomized. This meta-analysis has been cited in multiple articles referring to osteomyelitis 
and is often used as the benchmark study for this subject. This makes it the most relevant article related to imaging techniques in 
the setting of potential osteomyelitis. Within the meta-analysis, the studies were chosen with the following selection criteria: 
“Studies were en-rolled when information from the usual diagnostic performance 2x2 table… could be extracted about discrete foot 
and ankle cases, when 80% or more of the patients were 16 years or older, and when at least one site with the disease and one 
without were identified by the reference standard.” There were 2,053 potential studies excluded from the meta-analysis because 
PROVENZANO A. Critical review and clinical application of Kapoor, A. Arch Intern Med. 2007;167(2):125-132. 
 
VOL 1 ISS 1 / eP1000 / JANUARY 2015 
 
 
 
http://digitalcommons.wayne.edu/crp, © 2015 The Author(s) 
2 Licensed under Creative Commons Attribution Non-Commercial 4.0 
 
they were unable to meet the criteria mentioned above, or because a patient was reused in two studies. One study was also 
excluded that included a Charcot joint; this is important because in the article, the authors explain that MRI changes seen in 
osteomyelitis can be confused when a Charcot joint is present. This is an area of potential selection bias, which will be examined in 
detail later. 
Critical Appraisal 
This meta-analysis provides level 2a evidence using the Oxford and National Guidelines Clearinghouse criteria, because it provides 
data from cohort and randomized controlled trials. One of the advantages of this study is that it provides a cut-off point for the 
sensitivity of MRI, which is clinically relevant at 90%. It also provides receiver operator curves with relevant cut points and scales 
showing the area under curve (AUC) of MRI against the AUC of the three other tests. This kind of direct comparison makes it easy to 
see the global evidence and superiority of MRI graphically. The drawback of this technique is that it cannot determine the strengths 
and weaknesses of each individual data set, because it works as an average. A likelihood ratio matrix showing the strengths and 
weak-nesses of each individual study could strengthen this meta-analysis. Instead, the study uses diagnostic odds ratios, thus 
providing good evidence that the MRI is the best imaging technique to diagnose osteomyelitis of the foot and ankle in adults. Even in 
subsets that included different designs and more diverse patients, the superior performance of MRI remained statistically relevant. 
However, there are many flaws in this meta-analysis. For example, very few of the studies used in the meta-analysis followed up the 
MRI, and corroborated the evidence of osteomyelitis, with the gold standard of biopsy; thus, the comparison of MRI against other 
techniques for diagnosis was not entirely complete. Also, as noted earlier, the exclusion of documentation regarding Charcot foot is 
a potential confounding variable since this is often confused with osteomyelitis on MRI. It would be good to establish a best initial di-
agnostic procedure in this subset of patients.  
The largest and most relevant study within this meta-analysis is by Ledermann et al.1, which uses standard primary signs (the 
presence of focally decreased marrow signal on T1 weighted images, and increased marrow signal on T2 weighted images), as well 
as many secondary signs like ulcers or cortical disruption, on MRI to determine a positive result. The positive likelihood ratio of this 
study is 5.62 and the negative likelihood ratio is 0.112. These numbers mean that when MRI is positive there is a moderate increase 
in the likelihood of having osteomyelitis, and when MRI is negative there is moderate-strong decrease in the likelihood of disease.38 
These data agree with the claim put forth in the meta-analysis. 
 
Clinical Application 
After reading this study, it makes sense that we ordered an MRI for my patient because it provides the best initial 
imaging to diagnose osteomyelitis. Before the MRI results were available, the patient was started on empiric 
antibiotics. Making a correct diagnosis is essential to avoid continuing antibiotics, which have potentially serious 
side effects if the patient does not have osteomyelitis. For this patient, the MRI was positive and was confirmed by 
bone biopsy done for culture and identification of the organism.  
Three learning points to share: 
1.) I learned that bone scans are inferior to MRI for diagnosing osteomyelitis because of excess false positive and 
false negative results. 
2.) For my future career, I learned that I would not prescribe antibiotics to patients suspected of having 
osteomyelitis but who are clinically stable until the MRI results are available. 
3.) I want to share with my peers that different consultants can give conflicting advice and that ultimately, we as 
the provider need the ability to make judgment calls regarding appropriate treatment and evaluation plans. 
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